The invention is concerned with novel anthranilic acid derivatives of formula (I) ##STR00001## wherein R.sup.1 to R.sup.14, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds are HM74A agonists and can be used as medicaments.

 
Web www.patentalert.com

< Copper antagonist compositions

> Body Fluid Flow Control Method and Device

> OPTIMIZED STRAINS OF YARROWIA LIPOLYTICA FOR HIGH EICOSAPENTAENOIC ACID PRODUCTION

~ 00547